Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173130 | PMC |
| http://dx.doi.org/10.5114/ait.2020.93233 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association Between Impella Device Type and Short-Term Prognosis in Patients with Acute Myocardial Infarction-Related Cardiogenic Shock Receiving ECPELLA Support.
Int Heart J
December 2024
Second Department of Internal Medicine, University of Toyama.
Article Synopsis
- * Among 996 patients analyzed, those using the Impella 5.0/5.5 had significantly lower 30-day mortality rates compared to those using the smaller Impella 2.5/CP devices.
- * The findings suggest that using the larger Impella 5.5 or upgrading from the smaller model could improve survival rates in patients with advanced AMI-CS on ECPELLA support.
Ambulation in patients with peripheral veno-arterial extracorporeal membrane oxygenation and concomitant femoral intra-aortic balloon pump support.
Perfusion
October 2024
Cardiovascular Institute, Allegheny Health Network, Pittsburgh, PA, USA.
Introduction: The mobilization and ambulation of patients with severe cardiogenic shock supported with peripheral veno-arterial extracorporeal membrane oxygenation (pVA-ECMO) and concomitant femoral intra-aortic balloon pump (IABP) support is not well-described. This technical paper describes an ambulation protocol to prevent deconditioning in this critically ill patient population.
Methods: A protocol for the ambulation of patients with pVA-ECMO and concomitant IABP support was created in December 2022 and implemented at a single center.
Contemporary optimal therapeutic strategy with escalation/de-escalation of temporary mechanical circulatory support in patients with cardiogenic shock and advanced heart failure in Japan.
J Artif Organs
September 2024
Second Department of Internal Medicine, Toyama University, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan.
The utilization of temporary mechanical circulatory support (MCS) in the management of cardiogenic shock is experiencing a notable surge. Acute myocardial infarction remains the predominant etiology of cardiogenic shock, followed by heart failure. Recent findings from the DanGer Shock trial indicate that the percutaneous micro-axial flow pump support, in conjunction with standard care, significantly reduced 6-month mortality in patients with acute myocardial infarction-related cardiogenic shock compared to those receiving standard care alone.
View Article and Find Full Text PDFRisk Factors for Acute Kidney Injury in Adult Patients Under Veno-Arterial Extracorporeal Membrane Oxygenation Support.
J Cardiothorac Vasc Anesth
October 2024
Department of Cardiopulmonary Bypass, National Center for Cardiovascular Diseases & Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China. Electronic address:
Article Synopsis
- - The study examined the rates and risk factors for acute kidney injury (AKI) stage 3 in adults on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) at Fuwai Hospital from January 2020 to December 2022.
- - A total of 40 patients (53.3%) experienced AKI stage 3, and these patients had a significantly higher in-hospital mortality rate compared to those with AKI stage <3 (67.5% vs 34.3%).
- - Key risk factors identified for AKI stage 3 included hypertension, low pre-ECMO hemoglobin levels, and elevated pre-ECMO lactate and creatinine levels, highlighting
In patients supported with peripheral veno-arterial extracorporeal membrane oxygenation, what factors are associated with the development of spinal cord ischaemia?
Interdiscip Cardiovasc Thorac Surg
March 2024
Department of Cardiothoracic Surgery, Westmead Hospital, Westmead, NSW, Australia.
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'in patients supported with peripheral veno-arterial extracorporeal membrane oxygenation, what factors are associated with the development of spinal cord ischaemia'? Altogether, more than 22 papers were found using the reported search, of which 10 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!